help button home button Am J Pathol ASIP 2008 Summer Academy, Molecular Methcanisms of Human Disease: Injury, Inflammation, and Tissue Repair
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Order Full text via Infotrieve
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Flory, C. M.
Right arrow Articles by Warren, J. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Flory, C. M.
Right arrow Articles by Warren, J. S.

American Journal of Pathology, Vol 146, 450-462, Copyright © 1995 by American Society for Investigative Pathology


REGULAR ARTICLES

Regulatory roles of tumor necrosis factor-alpha and interleukin-1 beta in monocyte chemoattractant protein-1-mediated pulmonary granuloma formation in the rat

CM Flory, ML Jones, BF Miller and JS Warren
Pharmaceutical Research Division, Warner Lambert-Parke Davis, Ann Arbor, Michigan.

Intravenous infusion of particulate yeast cell wall glucan into rats results in the synchronous development of angiocentric pulmonary granulomas that are composed almost entirely of monocytes and macrophages. Previous studies indicate that locally produced monocyte chemoattractant protein-1 (MCP-1) is required for full granuloma development. Because tumor necrosis factor-alpha (TNF-alpha) and interleukin 1 (IL-1) can induce MCP-1 production in a variety of cell types, we sought to determine their potential regulatory roles in this model. A single infusion of anti-TNF-alpha antibody at the time of glucan infusion (time 0) markedly reduced MCP-1 mRNA levels at 1 and 6 hours but not at later time points; there was no effect on granuloma size or number measured at 48 hours. When multiple infusions of anti- TNF-alpha antibody were administered over a 23-hour period (0 to 23 hours), MCP-1 mRNA was reduced through 24 hours, there was a significant reduction in peak bronchoalveolar lavage fluid MCP-1 activity at 48 hours, and there were marked reductions in granuloma size and number at 48 hours. Similar results were observed in animals that received infusions of anti-IL-1 beta. Infusion of anti-IL-1 beta at time 0 resulted in moderate reductions in MCP-1 mRNA at 1 and 6 hours and had no effect on granuloma size or number measured at 48 hours. When multiple infusions of anti-IL-1 beta were administered over a 23-hour period (0 to 23 hours), MCP-1 mRNA was reduced through 24 hours, there was a moderate reduction in peak bronchoalveolar lavage fluid MCP-1 activity at 48 hours, and there were marked reductions in granuloma size and number at 48 hours. A single infusion of anti-TNF- alpha and anti-IL-1 beta together at time 0 resulted in marked reductions in whole lung MCP-1 and mRNA at 1 and 6 hours, but not at 24 hours. Multiple combined infusions of anti-TNF-alpha and anti-IL-1 beta over a 23-hour period resulted in additive reductions in MCP-1 mRNA through 24 hours, bronchoalveolar lavage fluid MCP-1 activity at 48 hours, and granuloma size and number at 48 hours. These data suggest that locally produced TNF-alpha and IL-1 beta play regulatory roles in glucan-induced pulmonary granulomatous vasculitis through the modulation of local MCP-1 production.


This article has been cited by other articles:


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
Y.-C. Hsieh, M. Frink, C.-H. Hsieh, M. A. Choudhry, M. G. Schwacha, K. I. Bland, and I. H. Chaudry
Downregulation of migration inhibitory factor is critical for estrogen-mediated attenuation of lung tissue damage following trauma-hemorrhage
Am J Physiol Lung Cell Mol Physiol, May 1, 2007; 292(5): L1227 - L1232.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
J. L. De Bleecker, B. De Paepe, I. E. Vanwalleghem, and J. M. Schroder
Differential expression of chemokines in inflammatory myopathies
Neurology, June 25, 2002; 58(12): 1779 - 1785.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. M. Hogaboam, C. L. Bone-Larson, S. Lipinski, N. W. Lukacs, S. W. Chensue, R. M. Strieter, and S. L. Kunkel
Differential Monocyte Chemoattractant Protein-1 and Chemokine Receptor 2 Expression by Murine Lung Fibroblasts Derived from Th1- and Th2-Type Pulmonary Granuloma Models
J. Immunol., August 15, 1999; 163(4): 2193 - 2201.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
S.-I. Hagiwara, M. Takeya, H. Suzuki, T. Kodama, L. J. W. van der Laan, G. Kraal, N. Kitamura, and K. Takahashi
Role of Macrophage Scavenger Receptors in Hepatic Granuloma Formation in Mice
Am. J. Pathol., March 1, 1999; 154(3): 705 - 720.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
G. Gudmundsson, A. Bosch, B. L. Davidson, D. J. Berg, and G. W. Hunninghake
Interleukin-10 Modulates the Severity of Hypersensitivity Pneumonitis in Mice
Am. J. Respir. Cell Mol. Biol., November 1, 1998; 19(5): 812 - 818.
[Abstract] [Full Text]


Home page
J. Pharmacol. Exp. Ther.Home page
K. S. Kilgore, K. L. Powers, M. M. Imlay, A. Malani, D. I. Allen, J. T. Beyer, M. B. Anderson, and J. S. Warren
The Carbohydrate Sialyl Lewisx (sLex) Sulfated Glycomimetic GM2941 Attenuates Glucan-Induced Pulmonary Granulomatous Vasculitis in the Rat
J. Pharmacol. Exp. Ther., July 1, 1998; 286(1): 439 - 446.
[Abstract] [Full Text]


Home page
J. Immunol.Home page
S. K. Lo, L. Bovis, R. Matura, B. Zhu, S. He, H. Lum, S. J. Turco, and J. L. Ho
Leishmania Lipophosphoglycan Reduces Monocyte Transendothelial Migration: Modulation of Cell Adhesion Molecules, Intercellular Junctional Proteins, and Chemoattractants
J. Immunol., February 15, 1998; 160(4): 1857 - 1865.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
B. Beck-Schimmer, R. C. Schimmer, R. L. Warner, H. Schmal, G. Nordblom, C. M. Flory, M. E. Lesch, H. P. Friedl, D. J. Schrier, and P. A. Ward
Expression of Lung Vascular and Airway ICAM-1 after Exposure to Bacterial Lipopolysaccharide
Am. J. Respir. Cell Mol. Biol., September 1, 1997; 17(3): 344 - 352.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1995 by the American Society for Investigative Pathology.